Generic Name ADALIMUMAB-AACF Review Date Began Wed, 07/05/2023 - 12:00 Review Date Completed Tue, 08/15/2023 - 12:00 Conclusion PDL Product Committee Month Mon, 01/01/2024 - 12:00